The PLOS One Editors issue this Editorial Note because this article [1,2] was identified as one of a series of submissions for which we have concerns about aspects of the peer review process. Readers are advised to interpret the article [1,2] with caution.
The Editors have no evidence of any author involvement in the peer review concerns.
References
- 1. Gebreyesus HA, Abreha GF, Besherae SD, Abera MA, Weldegerima AH, Gidey AH, et al. High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia. PLoS One. 2022;17(2):e0262610. pmid:35104300
- 2. Gebreyesus HA, Abreha GF, Besherae SD, Abera MA, Weldegerima AH, Gidey AH, et al. Correction: High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia. PLoS One. 2024;19(3):e0300773. pmid:38478566
Citation: The PLOS One Editors (2026) Editorial Note: High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia. PLoS One 21(5): e0349073. https://doi.org/10.1371/journal.pone.0349073
Published: May 11, 2026
Copyright: © 2026 The PLOS One Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.